Mycobacterium Tuberculosis Drug Resistance EQA/PT Scheme

To determine laboratories ability to detect and differentiate Mycobacterium tuberculosis drug resistance strains using their routine molecular diagnostic procedures.

Total Number of Challenges: 1
Number of Panel Members: 8
Distribution / Testing Period: Q3
Sample NA Target Source Cultured and/or Clinical material
Genotypic Variant Various drug resistance strains
Matrix Panel Format Sputum and/or Synthetic Sputum and/or Synthetic CSF
Panel Member Sample Volume 1.0 ml
Panel Sample Pre-treatment Requirement Pre-treatment may be required for the sputum samples – follow test manufacturer’s IFU.
Panel Analysis Type Resistance Gene Typing
Panel Testing Evaluated by various molecular methodologies
Storage / Shipment Conditions 2-8°C / Liquid Ambient
Accreditation / Regulatory Status Accredited to ISO 17043
SKU: QAB194209_1 Categories: , , , Tags: ,

$1,150.48